302440.KS SK Bioscience
₩36,750 -3.29%
Asia · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-3.29%
YTD
-20.20%
P/E
—
P/B
—
ROE
—
Div yield
—
Beta
0.75
Market cap
—
RSI (14)
50
Next earnings
—
Previous session
close of Oct 8, 2026 · EOD, no live order bookOpen
₩37,450
Close
₩36,750
VWAP (n/a)
—
Day high
₩37,500
Day low
₩36,750
Volume
88K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
Yahoo Finance · Jul 2
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
Yahoo Finance · Jun 2
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
Yahoo Finance · May 29
SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative
Yahoo Finance · May 27
SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia's VECOL to Advance Local Vaccine Manufacturing in Latin America
Yahoo Finance · May 26
SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate
Yahoo Finance · Aug 14
Headlines via Yahoo Finance · links open the source · not an endorsement.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell 302440.KS. Try it in the Lab to size a position and see the risk.